Abstract
In the February 1, 2019 issue of Antioxidants & Redox Signaling (vol. 30, no. 4; 489–504) the article entitled “rA1M-035, a Physicochemically Improved Human Recombinant α1-Microglobulin, Has Therapeutic Effects in Rhabdomyolysis-Induced Acute Kidney Injury” by Åkerström et al. requires correction.
The Swedish Foundation for Strategic Research was not listed in the Acknowledgments section as a source of funding for the article.
The Acknowledgments section originally read:
The authors gratefully acknowledge the invaluable help of Helena Karlsson with animal experiments and Camilla Svanstrӧm with the development and validation of A1M sandwich-ELISA. This work was supported by the Swedish Medical Research Council (VR), governmental ALF research grants to Lund University and Lund University Hospital, the Royal Physiographic Society in Lund, the Foundations of Greta and Johan Kock, Alfred Österlund, Lund University, and the Crafoord Foundation.
The Acknowledgments section now reads:
The authors gratefully acknowledge the invaluable help of Helena Karlsson with animal experiments and Camilla Svanstrӧm with the development and validation of A1M sandwich-ELISA. This work was supported by the Swedish Medical Research Council (VR), governmental ALF research grants to Lund University and Lund University Hospital, the Royal Physiographic Society in Lund, the Foundations of Greta and Johan Kock, Alfred Österlund, Lund University, the Crafoord Foundation,
The online version has been corrected to reflect this. The authors apologize for this error.